Vitaars provides remote-ICU telemedicine services, delivering diagnosis support, medical information, and safety consulting backed by a team of intensivists and certified critical-care nurses. The company positions itself as Japan’s only business-focused provider of remote ICU services and aims to expand those services to more medical institutions. Vitaars plans to use recent financing to accelerate R&D on remote-ICU systems and to strengthen its service operations and nationwide staffing/collaboration. It also intends to expand into adjacent medical areas and deepen partnerships across a broad range of fields. The company highlights goals of promoting medical DX, equalizing the quality of medical care in Japan, and contributing to healthcare workers’ work-style reform. Financially, Vitaars has received venture-debt financing to support these operational and R&D initiatives. T-ICU Co., Ltd. announced it received ¥570 million in funding on December 28, 2021. The financing was an equity round raised via a third-party allotment capital increase. Participating investors included Pasona Group Inc., Beyond Next Ventures Co., Ltd., and SMBC Venture Capital Co., Ltd. The article identifies SMBC Venture Capital and Beyond Next Ventures as existing investors. The announcement specifies the transaction method but does not detail use of proceeds or operating metrics.

Total raised

$6M

Funding rounds

2

Latest round

Debt Financing

Latest activity

Jan 2024